_template%20(1).png)
For more than 20 years, hormone therapy for menopause has carried a warning label from the Food and Drug Administration describing the medication’s risk of serious harms – namely, cancer, cardiovascular disease and possibly dementia.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
Sun-shielding skincare is having a moment. In recent years, the protection afforded by daily layers of SPF has made its way into modern beauty routines, with foundations, creams and concealers offering some degree of sun […]
BROOMFIELD, Colo., June 5, 2026 /PRNewswire/ — Quantinuum Inc. (Nasdaq: QNT) (“Quantinuum”) today announced the closing of its upsized initial public offering of 28,000,000 shares of its Class A common stock at an initial public […]
Normally what would be a six-month project has been spread over three years, the system said. Click here to view original post
Copyright © 2026 Biotech Networks
